GENTILINI, FABIANA
GENTILINI, FABIANA
DIPARTIMENTO DI BIOTECNOLOGIE CELLULARI ED EMATOLOGIA (attivo dal 01/01/1900 al 01/11/2018)
ARTERIAL AND VENOUS THROMBOSIS IN PATIENTS WITH MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE: INCIDENCE AND RISK FACTORS IN A COHORT OF 1,491 PATIENTS
2010 Za, T.; De Stefano, V; Rossi, E.; Petrucci, Mt; Andriani, A.; Annino, L; Cimino, Giuseppe; Caravita, T; Pisani, F.; Ciminello, A.; Torelli, F.; Villiva, N.; Bongarzoni, V; Rago, Angela; Betti, S.; Levi, A.; Felici, S.; Gentilini, Fabiana; Calabrese, E.; Leone, G.
Bortezomib, melphalan, and prednisone in elderly patients with relapsed/refractory multiple myeloma: A multicenter, open label phase 1/2 study.
2013 Petrucci, Mt; Levi, Anna; Bringhen, S; Scotti, S; Gentilini, Fabiana; Russo, S; Siniscalchi, A; Larocca, A; Grammatico, Sara; Boccadoro, M; Foa, Roberto; Palumbo, A.
Discontinuation of imatinib therapy after achievement of complete molecular response in a Ph+ CML patient treated while in long lasting complete cytogenetic remission (CCR) induced by interferon.
2006 Breccia, M; Diverio, D; Pane, F; Nanni, M; Russo, E; Biondo, F; Frustaci, A; Gentilini, Fabiana; Alimena, Giuliana
Efficacy of the BEACOPP regimen in refractory and relapsed Hodgkin lymphoma.
2009 Cavalieri, E; Matturro, A; Annechini, G; DE ANGELIS, F; Frattarelli, N; Gentilini, Fabiana; Grapulin, L; Sacco, M; Torelli, F; Vignetti, Marco; Mandelli, Franco; Foa, Roberto; Pulsoni, Alessandro
Haemolytic uremic syndrome during induction therapy in an acute promyelocytic leukemia patient with aberrant phenotype: a possible manifestation of retinoic acid syndrome.
2007 Breccia, M; Gentilini, Fabiana; Guarini, Anna; DE PROPRIS, Ms; Cimino, Giuseppe; LO COCO, F.
Impaired fasting glucose level as metabolic side effect of nilotinib in non-diabetic chronic myeloid leukemia patients resistant to imatinib.
2007 Breccia, M; Muscaritoli, Maurizio; Gentilini, Fabiana; Latagliata, R; Carmosino, I; ROSSI FANELLI, Filippo; Alimena, Giuliana
Myelodysplastic syndromes in patients under 50 years old: a single institution experience
2005 Massimo, Breccia; Andrea, Mengarelli; Marco, Mancini; Francesca, Biondo; Gentilini, Fabiana; Roberto, Latagliata; Mandelli, Franco; Alimena, Giuliana
Occurrence of thrombotic events in acute promyelocytic leukemia correlates with consistent immunophenotypic and molecular features
2007 M., Breccia; G., Avvisati; R., Latagliata; I., Carmosino; Guarini, Anna; M. S., De Propris; Gentilini, Fabiana; M. C., Petti; Cimino, Giuseppe; F., Mandelli; F., Lo Coco
Ocular side effects in chronic myeloid leukemia patients treated with imatinib.
2008 Breccia, M; Gentilini, Fabiana; Cannella, L; Latagliata, R; Carmosino, I; Frustaci, A; Alimena, Giuliana
Refractory anemia with excess of blasts in transformation re-evaluated with the WHO criteria: identification of subgroups with different survival
2007 Breccia, M; Latagliata, R; Carmosino, I; Gentilini, Fabiana; D'Elia, Gm; Levi, A; Natalino, F; Frustaci, A; DE CUIA, Mr; Alimena, Giuliana
SUSTAINED MOLECULAR REMISSION AFTER LOW DOSE GEMTUZUMAB-OZOGAMICIN IN ELDERLY PATIENTS WITH ADVANCED ACUTE PROMYELOCYTIC LEUKEMIA
2007 Breccia, M; Cimino, Giuseppe; Diverio, D; Gentilini, Fabiana; Mandelli, Franco; LO COCO, F.
Target-Related therapeutic strategies in Myeloma Multiple.
2009 De Benedictis, C; Ricciardi, Maria Rosaria; Milella, M; Calabrese, E; Libotte, F; Bergamo, P; Santinelli, S; Decandia, S; Levi, A; Gentilini, Fabiana; Foà, R; Tafuri, Agostino; Petrucci, M. T.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| ARTERIAL AND VENOUS THROMBOSIS IN PATIENTS WITH MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE: INCIDENCE AND RISK FACTORS IN A COHORT OF 1,491 PATIENTS | 2010 | Za, T.; De Stefano, V; Rossi, E.; Petrucci, Mt; Andriani, A.; Annino, L; Cimino, Giuseppe; Caravita, T; Pisani, F.; Ciminello, A.; Torelli, F.; Villiva, N.; Bongarzoni, V; Rago, Angela; Betti, S.; Levi, A.; Felici, S.; Gentilini, Fabiana; Calabrese, E.; Leone, G. | |
| Bortezomib, melphalan, and prednisone in elderly patients with relapsed/refractory multiple myeloma: A multicenter, open label phase 1/2 study. | 2013 | Petrucci, Mt; Levi, Anna; Bringhen, S; Scotti, S; Gentilini, Fabiana; Russo, S; Siniscalchi, A; Larocca, A; Grammatico, Sara; Boccadoro, M; Foa, Roberto; Palumbo, A. | |
| Discontinuation of imatinib therapy after achievement of complete molecular response in a Ph+ CML patient treated while in long lasting complete cytogenetic remission (CCR) induced by interferon. | 2006 | Breccia, M; Diverio, D; Pane, F; Nanni, M; Russo, E; Biondo, F; Frustaci, A; Gentilini, Fabiana; Alimena, Giuliana | |
| Efficacy of the BEACOPP regimen in refractory and relapsed Hodgkin lymphoma. | 2009 | Cavalieri, E; Matturro, A; Annechini, G; DE ANGELIS, F; Frattarelli, N; Gentilini, Fabiana; Grapulin, L; Sacco, M; Torelli, F; Vignetti, Marco; Mandelli, Franco; Foa, Roberto; Pulsoni, Alessandro | |
| Haemolytic uremic syndrome during induction therapy in an acute promyelocytic leukemia patient with aberrant phenotype: a possible manifestation of retinoic acid syndrome. | 2007 | Breccia, M; Gentilini, Fabiana; Guarini, Anna; DE PROPRIS, Ms; Cimino, Giuseppe; LO COCO, F. | |
| Impaired fasting glucose level as metabolic side effect of nilotinib in non-diabetic chronic myeloid leukemia patients resistant to imatinib. | 2007 | Breccia, M; Muscaritoli, Maurizio; Gentilini, Fabiana; Latagliata, R; Carmosino, I; ROSSI FANELLI, Filippo; Alimena, Giuliana | |
| Myelodysplastic syndromes in patients under 50 years old: a single institution experience | 2005 | Massimo, Breccia; Andrea, Mengarelli; Marco, Mancini; Francesca, Biondo; Gentilini, Fabiana; Roberto, Latagliata; Mandelli, Franco; Alimena, Giuliana | |
| Occurrence of thrombotic events in acute promyelocytic leukemia correlates with consistent immunophenotypic and molecular features | 2007 | M., Breccia; G., Avvisati; R., Latagliata; I., Carmosino; Guarini, Anna; M. S., De Propris; Gentilini, Fabiana; M. C., Petti; Cimino, Giuseppe; F., Mandelli; F., Lo Coco | |
| Ocular side effects in chronic myeloid leukemia patients treated with imatinib. | 2008 | Breccia, M; Gentilini, Fabiana; Cannella, L; Latagliata, R; Carmosino, I; Frustaci, A; Alimena, Giuliana | |
| Refractory anemia with excess of blasts in transformation re-evaluated with the WHO criteria: identification of subgroups with different survival | 2007 | Breccia, M; Latagliata, R; Carmosino, I; Gentilini, Fabiana; D'Elia, Gm; Levi, A; Natalino, F; Frustaci, A; DE CUIA, Mr; Alimena, Giuliana | |
| SUSTAINED MOLECULAR REMISSION AFTER LOW DOSE GEMTUZUMAB-OZOGAMICIN IN ELDERLY PATIENTS WITH ADVANCED ACUTE PROMYELOCYTIC LEUKEMIA | 2007 | Breccia, M; Cimino, Giuseppe; Diverio, D; Gentilini, Fabiana; Mandelli, Franco; LO COCO, F. | |
| Target-Related therapeutic strategies in Myeloma Multiple. | 2009 | De Benedictis, C; Ricciardi, Maria Rosaria; Milella, M; Calabrese, E; Libotte, F; Bergamo, P; Santinelli, S; Decandia, S; Levi, A; Gentilini, Fabiana; Foà, R; Tafuri, Agostino; Petrucci, M. T. |